Trials / Unknown
UnknownNCT05729217
Long COVID Symptoms in SARS-CoV-2-positive Children in China
Long COVID Symptoms in SARS-CoV-2-positive Children Aged 6-18 Years in China: a Consequential Observation Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Tim Shi · Academic / Other
- Sex
- All
- Age
- 7 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn about in children aged 6-18 years, after the acute phase of SARS-CoV-2 infection, the COVID symptoms or Long COVID symptoms to impact their daily activities. We aimed to investigate the prevalence of long-lasting symptoms, the duration and intensity of symptoms, quality of life, number of sick days or absences from school, and psychological and social outcomes. The participants will be asked to fill in Long COVID symptom burden questionnaires who had been infected with SARS-CoV-2 as self-reported PRC test or antigen test positive.
Detailed description
The goal of this observational study is to learn about in children aged 6-18 years, after the acute phase of SARS-CoV-2 infection, the COVID symptoms or Long COVID symptoms to impact their daily activities. We aimed to investigate the prevalence of long-lasting symptoms, the duration and intensity of symptoms, quality of life, number of sick days or absences from school, and psychological and social outcomes. The participants will be asked to fill in SBQ-Long COVID symptom burden survey questionnaires who had been infected with SARS-CoV-2 as self-reported PRC test or antigen test positive. The survey questionnaires will be filled every two weeks after the participants have been tested SARS-CoV-2 positive.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | SBQ-LC survey | Symptom burden questionnaires of Long COVID |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2024-01-31
- Completion
- 2024-01-31
- First posted
- 2023-02-15
- Last updated
- 2023-03-02
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05729217. Inclusion in this directory is not an endorsement.